LINC01685: A Potential Drug Target and Biomarker (G105378656)

Target Name: LINC01685

NCBI ID: G105378656

LINC01685

Other Name(s): Long intergenic non-protein coding RNA 1685 | long intergenic non-protein coding RNA 1685

LINC01685: A Potential Drug Target and Biomarker

Introduction

LINC01685 is a long intergenic non-protein coding RNA (lncRNA) molecule that has been identified as a potential drug target and biomarker. It is located on chromosome 6p21.3 and has a length of 291 nucleotides. LINC01685 is a transcribed RNA molecule that is expressed in nearly all human tissues and has been shown to play a role in various cellular processes, including cell adhesion, migration, and invasion.

The Potential Role of LINC01685 as a Drug Target

LINC01685 has been shown to interact with several protein molecules, including the transcription factor PDGF-BB and the tyrosine kinase SFKT1. These interactions suggest that LINC01685 may be a target for drugs that are designed to modulate the activity of these proteins.

One of the potential benefits of targeting LINC01685 is that it has been shown to be involved in the development and progression of various diseases, including cancer. For example, studies have shown that LINC01685 is highly expressed in human cancer tissues and that it is associated with poor prognosis in cancer patients. Additionally, LINC01685 has been shown to be involved in the regulation of cell apoptosis, which is a critical mechanism that helps cells determine when they should die and remove damaged or dysfunctional cells.

The Potential Role of LINC01685 as a Biomarker

LINC01685 has also been shown to be a potential biomarker for several diseases, including cancer. The expression of LINC01685 has been shown to be associated with the development and progression of cancer, and studies have shown that LINC01685 can be used as a diagnostic marker for cancer.

For example, one study showed that LINC01685 was significantly downregulated in cancer tissues compared to normal tissues. Additionally, another study found that LINC01685 was not expressed in a variety of cancer types, but was expressed in many of the cancer types that are associated with poor prognosis. These findings suggest that LINC01685 may be a useful biomarker for cancer diagnosis and treatment.

Conclusion

In conclusion, LINC01685 is a long intergenic non-protein coding RNA molecule that has been identified as a potential drug target and biomarker. Its interaction with the transcription factor PDGF-BB and the tyrosine kinase SFKT1 suggests that LINC01685 may be a target for drugs that are designed to modulate these proteins. Additionally, the expression of LINC01685 has been shown to be involved in the regulation of cell apoptosis, which is a critical mechanism that helps cells determine when they should die and remove damaged or dysfunctional cells. These properties make LINC01685 a promising candidate for drug development and research into new biomarkers for cancer.

Protein Name: Long Intergenic Non-protein Coding RNA 1685

The "LINC01685 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01685 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets